Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Newly Proposed ALBI Grade and ALBI-T Score as Tools for Assessment of Hepatic Function and Prognosis in Hepatocellular Carcinoma Patients
Atsushi Hiraoka, Takashi Kumada, Kojiro Michitaka, et al.
Liver Cancer (2018) Vol. 8, Iss. 5, pp. 312-325
Open Access | Times Cited: 119

Showing 1-25 of 119 citing articles:

Predictive value of serum albumin levels on cancer survival: a prospective cohort study
Quan Tang, Xu Li, Chunrong Sun
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 19
Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis
Atsushi Hiraoka, Takashi Kumada, Kazuya Kariyama, et al.
Hepatology Research (2018) Vol. 49, Iss. 1, pp. 111-117
Open Access | Times Cited: 87
Association between sarcopenia and clinical outcomes in patients with hepatocellular carcinoma: an updated meta-analysis
Yusheng Guo, Yanqiao Ren, Licheng Zhu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 30
Psoas Muscle Index as an Independent Predictor of Survival in Patients with Hepatocellular Carcinoma Receiving Systemic Targeted Therapy
Kenji Imai, Koji Takai, Masashi Aiba, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 209-209
Open Access | Times Cited: 1
The Prognostic Value of Platelet‐Albumin‐Bilirubin Score in Patients Undergoing Transcatheter Aortic Valve Replacement
Xueting Duan, Liangzhen Qu, Han Chen
Clinical Cardiology (2025) Vol. 48, Iss. 3
Open Access | Times Cited: 1
HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort
Yasuhito Tanaka, Eiichi Ogawa, Chung‐Feng Huang, et al.
Hepatology International (2020) Vol. 14, Iss. 6, pp. 1023-1033
Closed Access | Times Cited: 56
EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis
Kazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, et al.
Liver Cancer (2020) Vol. 9, Iss. 6, pp. 734-743
Open Access | Times Cited: 51
Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study
Shigeo Shimose, Hideki Iwamoto, Masatoshi Tanaka, et al.
Cancers (2021) Vol. 13, Iss. 1, pp. 160-160
Open Access | Times Cited: 49
Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab
Chiun Hsu, Lorenza Rimassa, Hui‐Chuan Sun, et al.
Therapeutic Advances in Medical Oncology (2021) Vol. 13
Open Access | Times Cited: 38
Prognostic impact of albumin-bilirubin score on the prediction of in-hospital mortality in patients with heart failure: a retrospective cohort study
Han Su, Chuanhe Wang, Fei Tong, et al.
BMJ Open (2022) Vol. 12, Iss. 1, pp. e049325-e049325
Open Access | Times Cited: 24
Contemporary applications of Y90 for the treatment of hepatocellular carcinoma
Qian Yu, Michael Khanjyan, Nicholas Fidelman, et al.
Hepatology Communications (2023) Vol. 7, Iss. 10
Open Access | Times Cited: 15
Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review
Howard J. Lim, Ravi Ramjeesingh, David Liu, et al.
JNCI Journal of the National Cancer Institute (2020) Vol. 113, Iss. 2, pp. 123-136
Open Access | Times Cited: 36
Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria
Hironori Ochi, Atsushi Hiraoka, Masashi Hirooka, et al.
Journal of Gastroenterology (2020) Vol. 56, Iss. 1, pp. 90-100
Open Access | Times Cited: 35
Prognostic Value of the Systemic Immune-Inflammation Index and Prognostic Nutritional Index in Patients With Medulloblastoma Undergoing Surgical Resection
Sihan Zhu, Zhuqing Cheng, Yuanjun Hu, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 29
Lenvatinib Combined With a PD-1 Inhibitor as Effective Therapy for Advanced Intrahepatic Cholangiocarcinoma
Lulu Xie, Jingzheng Huang, Linling Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Interpretations of the Role of Plasma Albumin in Prognostic Indices: A Literature Review
Kim Oren Gradel
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6132-6132
Open Access | Times Cited: 12
Development and Validation of a Predictive Model for Liver Failure After Transarterial Chemoembolization Using Gadoxetic Acid-Enhanced MRI and Functional Liver Imaging Score
Xinru Wu, Yihuan Wang, Yiwei He, et al.
Academic Radiology (2025)
Closed Access
TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma
Weilang Wang, Qi Zhang, Ying Cui, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 193-203
Open Access
Comparison analysis of ICIs and chemotherapy combined with or without lenvatinib as first-line treatment of unresectable intrahepatic cholangiocarcinoma
Miao Li, Tong Li, Rongxin Chen, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Prognostic impact of albumin-bilirubin score in predicting the long-term survival of distal cholangiocarcinoma after radical surgery
Jincan Huang, You-Wei Ma, Han-Xuan Wang, et al.
Research Square (Research Square) (2025)
Closed Access
Association of albumin-bilirubin grade with short- and long-term mortality in patients with heart failure: a cohort study using restricted cubic splines and propensity score matching
Xi Gao, Cheng Li, Yurou Wang, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access
Prognostic impact of albumin-bilirubin score in predicting the long-term survival of distal cholangiocarcinoma after radical surgery
Jincan Huang, You-Wei Ma, Han-Xuan Wang, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
Shu‐Yein Ho, Po‐Hong Liu, Chia‐Yang Hsu, et al.
PLoS ONE (2017) Vol. 12, Iss. 7, pp. e0180408-e0180408
Open Access | Times Cited: 39
Liver resection in Cirrhotic liver: Are there any limits?
Albert C. Y. Chan, Alfred Wei Chieh Kow, Taizo Hibi, et al.
International Journal of Surgery (2020) Vol. 82, pp. 109-114
Open Access | Times Cited: 28
Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection
Juncheng Wang, Jingyu Hou, Jiancong Chen, et al.
European Journal of Cancer (2021) Vol. 155, pp. 85-96
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top